Kholoud AMER Elnaggar

Ms. Kholoud AMER Elnaggar

Information Technology, Mansoura Univeristy, Cairo, Al Qāhirah, Egypt

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
Kholoud AMER ElnaggarKholoud AMER Elnaggar
Kholoud AMER Elnaggar
MEMostafa Elgayar
Mostafa Elgayar
MEMOHAMMED Elmogy
MOHAMMED Elmogy
Background: Mental disorders are disturbances of brain functions that cause cognitive, affective, volitional, and behavioral functions to be disrupted to varying degrees. One of these disorders is depression, a significant factor contributing to the increase in suicide cases worldwide. Consequently, depression has become a significant public health issue globally. Electroencephalogram (EEG) data can be utilized to diagnose mild depression disorder (MDD), offering valuable insights into the pathophysiological mechanisms underlying mental disorders and enhancing the understanding of MDD. Methods: This survey emphasizes the critical role of EEG in advancing artificial intelligence (AI)-driven approaches for depression diagnosis. By focusing on studies that integrate EEG with machine learning (ML) and deep learning (DL) techniques, we systematically analyze methods utilizing EEG signals to identify depression biomarkers. The survey highlights advancements in EEG preprocessing, feature extraction, and model development, showcasing how these approaches enhance the diagnostic precision, scalability, and automation of depression detection. Results: This survey is distinguished from prior reviews by addressing their limitations and providing researchers with valuable insights for future studies. It offers a comprehensive comparison of ML and DL approaches utilizing EEG and an overview of the five key steps in depression detection. The survey also presents existing datasets for depression diagnosis and critically analyzes their limitations. Furthermore, it explores future directions and challenges, such as enhancing diagnostic robustness with data augmentation techniques and optimizing EEG channel selection for improved accuracy. The potential of transfer learning and encoder-decoder architectures to leverage pre-trained models and enhance diagnostic performance is also discussed. Advancements in feature extraction methods for automated depression diagnosis are highlighted as avenues for improving ML and DL model performance. Additionally, integrating Internet of Things (IoT) devices with EEG for continuous mental health monitoring and distinguishing between different types of depression are identified as critical research areas. Finally, the review emphasizes improving the reliability and predictability of computational intelligence-based models to advance depression diagnosis. Conclusions: This study will serve as a well-organized and helpful reference for researchers working on detecting depression using EEG signals and provide insights into the future directions outlined above, guiding further advancements in the field.

7 November 2026 in Bioengineering
Verified
Journal Article
Open access
PDF file
Kholoud AMER ElnaggarKholoud AMER Elnaggar
Kholoud AMER Elnaggar
MEMostafa Elgayar
Mostafa Elgayar
MEMOHAMMED Elmogy
MOHAMMED Elmogy
Electroencephalography (EEG)-based depression detection studies commonly reduce clinical severity scores, such as the Patient Health Questionnaire-9 (PHQ-9), to binary diagnostic labels, thereby discarding ordinal information that may be useful for representation learning. This study proposes PHQ-9-guided ordinal contrastive learning (CE+OC), a training objective that uses PHQ-9 scores as privileged ordinal supervision during training while requiring only EEG at inference. PHQ-9 severity distances guide contrastive pair selection and scale the embedding separation margin, using clinical distances to guide the latent EEG space without an explicit patient-ranking objective. The method was evaluated on the Multi-modal Open Dataset for Mental-Disorder Analysis (MODMA) using strict leave-one-subject-out cross-validation across 53 subjects with 128-channel resting-state EEG. The primary representation finding was improved full-cohort PHQ-9 recoverability: a cross-validated held-out PHQ-9 probe showed that CE+OC increased recoverable PHQ-9 rank correlation from 7.8% to 33.6% (paired two-sided permutation p=0.031), an absolute gain of 25.7 percentage points, and reduced mean absolute PHQ-9 error from 27.8% to 22.8% of the 27-point PHQ-9 range (18.1% relative reduction; paired two-sided Wilcoxon p=0.011; bootstrap 95% CI for Δρ: 3.0% to 49.6%). CE+OC also showed descriptive diagnostic differences on MODMA: AUC increased from 59.8% to 69.3%, balanced accuracy from 59.5% to 66.0%, specificity from 69.0% to 86.2%, precision for major depressive disorder (MDD) from 57.1% to 73.3%, and MDD-F1 from 53.3% to 56.4%. False positives decreased from 31.0% to 13.8% of healthy subjects, although sensitivity decreased from 50.0% to 45.8%. A separate LOSO diagnosis evaluation on the independently acquired Mumtaz cohort achieved an AUC of 85.1%; it provides secondary evidence that the pipeline is feasible in a second cohort, but it is not a cross-dataset transfer experiment. A true-diagnosis-only control achieved ρ=0.502 and MAE 2.142 points, and within-MDD probe correlation remained negative (ρ=−0.424). The findings support increased full-cohort PHQ-9 recoverability relative to CE-only, not established information beyond diagnosis; diagnostic difference intervals include zero, and the model is not validated for stand-alone screening.